GlassScriptPhysician profile
Donald Arms
NPI 1548233661
$986.02
in general payments reported to CMS, 2019-2025
16 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $100 · 2022: $233 · 2023: $125 · 2024: $216 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $289.67 | 2021-2025 | Evenity, Prolia |
| Stryker Corporation | $155.21 | 2021-2025 | 1788, T2 |
| Depuy Synthes Sales INC. | $94.97 | 2021-2025 | Monovisc, Orthovisc |
| Abbvie INC. | $75.29 | 2021-2025 | Dalvance |
| Mimedx Group, INC. | $71.00 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $68.78 | 2023-2025 | Exparel, Iovera, Zilretta |
| Polynovo North America LLC | $44.70 | 2024-2025 | Novosorb Btm |
| Melinta Therapeutics, LLC | $39.31 | 2022-2023 | Orbactiv, Kimyrsa |
| Pacira Therapeutics, INC. | $28.03 | 2021 | |
| Novo Nordisk INC | $21.59 | 2022 | |
| Bioventus LLC | $20.05 | 2022 | |
| Dynasplint Systems INC. | $19.35 | 2025 | Dynasplint |
| Reprise Biomedical, INC. | $15.51 | 2024 | Miro3d |
| Orthofix Medical, INC. | $14.84 | 2024 | Physio-Stim |
| Convatec INC. | $13.96 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Arms listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.